Singapore: South Korea will channelize a combined $8.9 billion (10 trillion Won) on developing 20 new drugs over the nex...
Singapore: CEVEC Pharmaceuticals, the developer of a novel human expression system derived from amniocytes, and Yuhan Co...
Singapore: Kinex Pharmaceuticals and Hanmi Pharmaceutical announced the execution of an agreement for Kinex Pharmaceutic...
Singapore: Seegene, a leading developer of multiplexed molecular technologies and diagnostic tests, has given bioMéri...
VM202 is a DNA-based drug that is designed to produce two isoforms of hepatocyte growth factor (HGF) - HGF 728 and HGF ...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
Samsung India strengthened its presence in the health and medical equipment business in the country by launching digital...
Telemedicine is re-defining access to healthcare in many ways. It has, in particular, proved to be an effective solution...
Singapore: CrystalGenomics, a clinical stage biopharmaceutical company headquartered in Korea, has received the draft of...
Singapore: Samsung Electronics is set to launch all-in-one advanced system logic chip, Bio-Processor, for the health-ori...
Singapore: Scientists at Korean biotech company PharmAbcine are completing formulation and stability studies based on Op...
Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Part...
The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 bill...
Singapore: TheraVida and SK Chemicals announced the execution of a license agreement for two of TheraVida's proprietary ...
Singapore: Seegene, a leading developer of multiplex molecular technologies and multiplex molecular diagnostic tests, an...
‎Singapore: Miltenyi Biotec, a cell innovation company, has opened a new office in Seoul, South Korea, enlarging t...
Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule...
